Literature DB >> 1829348

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

S Rantapää-Dahlqvist1, S Wållberg-Jonsson, G Dahlén.   

Abstract

Lipoprotein (a), (Lp(a)), an independent atherogenic factor, was significantly increased in 93 patients with classical, seropositive rheumatoid arthritis of median disease activity. In the patients with Lp(a) concentrations above the upper reference value of 480 mg/l there was a significant correlation between Lp(a) and the concentration of orosomucoid, erythrocyte sedimentation rate, and the platelet count. The plasma concentrations of cholesterol and high density lipoprotein-cholesterol in both male and female patients were significantly lower than in controls. Apolipoprotein B and apolipoprotein AI in the patients correlated significantly with total cholesterol and high density lipoprotein-cholesterol respectively.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1829348      PMCID： PMC1004438          DOI： 10.1136/ard.50.6.366

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  21 in total

1.  The influence of drugs and disease activity on biochemical and haematological data in rheumatoid arthritis.

Authors:  P Wilding; M J Kendall; R Holder; J A Grimes; M Farr
Journal:  Clin Chim Acta       Date:  1975-10-15       Impact factor: 3.786

2.  Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of LP(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma.

Authors:  G Utermann; H G Kraft; H J Menzel; T Hopferwieser; C Seitz
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

3.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.

Authors:  J W McLean; J E Tomlinson; W J Kuang; D L Eaton; E Y Chen; G M Fless; A M Scanu; R M Lawn
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

4.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment.

Authors:  K L Svenson; H Lithell; R Hällgren; B Vessby
Journal:  Arch Intern Med       Date:  1987-11

5.  Preregistration rotation including general practice at St Mary's Hospital Medical School.

Authors:  C M Harris; H A Dudley; B Jarman; P H Kidner
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

6.  Human plasma lipoprotein [a]. Structural properties.

Authors:  J W Gaubatz; C Heideman; A M Gotto; J D Morrisett; G H Dahlen
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

7.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

Authors:  D L Eaton; G M Fless; W J Kohr; J W McLean; Q T Xu; C G Miller; R M Lawn; A M Scanu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity.

Authors:  K L Svenson; H Lithell; R Hällgren; I Selinus; B Vessby
Journal:  Arch Intern Med       Date:  1987-11

9.  Hypocholesterolaemia and abnormal high-density lipoprotein in rheumatoid arthritis.

Authors:  M Lorber; M Aviram; S Linn; Y Scharf; J G Brook
Journal:  Br J Rheumatol       Date:  1985-08

10.  Apolipoproteins and coronary artery disease.

Authors:  B A Kottke; A R Zinsmeister; D R Holmes; R W Kneller; B J Hallaway; S J Mao
Journal:  Mayo Clin Proc       Date:  1986-05       Impact factor: 7.616
View more
  30 in total

1.  Dyslipidemia and rheumatoid arthritis.

Authors:  R D Situnayake; G Kitas
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

Review 2.  Inflammation and rheumatoid arthritis.

Authors:  Amit Kumar Shrivastava; Aparna Pandey
Journal:  J Physiol Biochem       Date:  2012-10-31       Impact factor: 4.158

Review 3.  Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.

Authors:  Matxalen Amezaga Urruela; Maria E Suarez-Almazor
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

Review 4.  Metabolomics approach in allergic and rheumatic diseases.

Authors:  Rossana Scrivo; Luca Casadei; Mariacristina Valerio; Roberta Priori; Guido Valesini; Cesare Manetti
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

5.  Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis.

Authors:  A Kavanaugh
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

6.  Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease.

Authors:  S M Jones; C P Harris; J Lloyd; C A Stirling; J P Reckless; N J McHugh
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

7.  Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Authors:  Cynthia S Crowson; Silvia Rollefstad; Eirik Ikdahl; George D Kitas; Piet L C M van Riel; Sherine E Gabriel; Eric L Matteson; Tore K Kvien; Karen Douglas; Aamer Sandoo; Elke Arts; Solveig Wållberg-Jonsson; Lena Innala; George Karpouzas; Patrick H Dessein; Linda Tsang; Hani El-Gabalawy; Carol Hitchon; Virginia Pascual Ramos; Irazú Contreras Yáñez; Petros P Sfikakis; Evangelia Zampeli; Miguel A Gonzalez-Gay; Alfonso Corrales; Mart van de Laar; Harald E Vonkeman; Inger Meek; Anne Grete Semb
Journal:  Ann Rheum Dis       Date:  2017-09-06       Impact factor: 19.103

8.  Plasma lipids and lipoproteins in juvenile chronic arthritis.

Authors:  A Bakkaloglu; B Kirel; S Ozen; U Saatçi; N Beşbaş
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

9.  Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Authors:  G Vaudo; S Marchesi; R Gerli; R Allegrucci; A Giordano; D Siepi; M Pirro; Y Shoenfeld; G Schillaci; E Mannarino
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

10.  Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Tracey E Toms; Vasileios F Panoulas; Karen M J Douglas; Helen R Griffiths; George D Kitas
Journal:  Arthritis Res Ther       Date:  2008-12-17       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.